Jon Kroll Bjerregaard – Research output — The Capital Region of Denmark's Research Portal

Research activity per year

1 Poster
1 Journal article

1 results

Filter

2021
A randomized phase 2 trial of first-line docetaxel, carboplatin, capecitabine (CTX) and epirubicin, oxaliplatin, capecitabine (EOX) in advanced esophagogastric adenocarcinoma
Petersen, P. C., Petersen, L. N., Vogelius, I., Bjerregaard, J. K. & Baeksgaard, L., Jul 2021, In: Acta Oncologica. 60, 7, p. 948-953 6 p.
Research output: Contribution to journal › Journal article › Research › peer-review